Type 2 pseudohypoaldosteronism: new insights into renal potassium, sodium, and chloride handling.
Proctor
Gregory
G
Division of Nephrology, University of Colorado Health Sciences Center, Denver, CO, USA. gregory.proctor@uchsc.edu
Linas
Stuart
S
D000328:Adult; D000450:Aldosterone / Q000502:physiology; D002712:Chlorides / Q000378:metabolism*; D004573:Electrolytes / Q000378:metabolism; D006801:Humans; D006947:Hyperkalemia / Q000209:etiology; D047908:Intracellular Signaling Peptides and Proteins; D007668:Kidney / Q000378:metabolism*; D008297:Male; D015778:Minor Histocompatibility Antigens; D011188:Potassium / Q000378:metabolism*; D020033:Protein Isoforms; D017346:Protein Serine-Threonine Kinases / Q000502:physiology; D011546:Pseudohypoaldosteronism / Q000150:complications / Q000378:metabolism*; D012964:Sodium / Q000378:metabolism*; D000076204:WNK Lysine-Deficient Protein Kinase 1; D014882:Water-Electrolyte Balance / Q000502:physiology
D002712:Chlorides; D004573:Electrolytes; D047908:Intracellular Signaling Peptides and Proteins; D015778:Minor Histocompatibility Antigens; D020033:Protein Isoforms; D000450:Aldosterone; D012964:Sodium; D017346:Protein Serine-Threonine Kinases; D000076204:WNK Lysine-Deficient Protein Kinase 1; C498743:WNK1 protein, human; C433806:WNK4 protein, human; D011188:Potassium